Authors : Laxman Kumar Soni, K.C Agarwal, Priyanka Soni
DOI : 10.18231/j.ijirm.2021.033
Volume : 6
Issue : 3
Year : 2021
Page No : 152-155
Background: Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection by COVID-19 can result in a range of clinical outcomes, from asymptomatic to severe life-threatening course or death.
The purpose of our research was to evaluate the presentation of COVID19 disease based on the clinical and radiological characteristics of our population.
Materials and Methods: 100 COVID19 patients recorded by RTPCR. Clinical, biochemical and radiological data from April-May, 2021.
Results: Of the 100 patients, in our study 66% were males and 26% patients had history of recent travel. Majority of patients were asymptomatic and don’t have comorbid illness. Thrombocytopenia and lymphopenia, increased levels of lactate dehydrogenase (LDH) and serum ferritin and C-reactive protein were common in these patients. CT finding were 63% had normal CT chest. Among the 37% patients who had CT chest findings, 25% had bilateral diseases, 8% patients had right lung involvement while 4% patients have left lung involvement.
Conclusion: COVID-19 disease has a relatively mild course in this part of the subcontinent. Clinical and laboratory findings are similar to those found in viral diseases. Studies involving larger sample size and interventional trials are need of the hour.
Keywords: Clinico-radiological, coronavirus disease 2019, Lymphopenia